Feedback / Questions
fulranumab (AMG-403) - Amgen
JNJ: Pharmaceutical Business Review
(Johnson and Johnson Ltd)
-
May 24, 2015 -
“Fulranumab Improves Pain and Function in Osteoarthritis”
P2 data
•
Pain
http://edge.media-server.com/m/p/7c9tc824
May 24, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.